Compared to the Pfizer and Moderna vaccines, Johnson & Johnson's single-shot vaccine always had slightly lower efficacy. Peak efficacy from the two-shot Pfizer and Moderna vaccines was 95% and 94%, respectively, against symptomatic illness.
All three currently authorized vaccines are still working well to dramatically reduce the risk of being hospitalized, but as months pass and with the emergence of new COVID-19 variants, the vaccines are losing their power to prevent more mild breakthrough infections. PHOTO: FILE - In this July 30, 2021, file photo, Jay Vojno gets the Johnson & Johnson COVID-19 vaccine, in New York.
MORE: Johnson & Johnson vaccine seems to stand up against delta variant, preliminary research suggests
HiMyNameIsSeton 'suggests'
Got my J&J shot over six months ago and still wondering why they’re not talking about boosters for us. I almost feel like lying about my vaccine status and just getting one shot of Pfizer or Moderna.
chazkellyisms 🕺